1. Home
  2. BTOC vs CGTX Comparison

BTOC vs CGTX Comparison

Compare BTOC & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BTOC

Armlogi Holding Corp.

N/A

Current Price

$0.26

Market Cap

12.2M

Sector

N/A

ML Signal

N/A

Logo Cognition Therapeutics Inc.

CGTX

Cognition Therapeutics Inc.

N/A

Current Price

$1.15

Market Cap

94.5M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BTOC
CGTX
Founded
2020
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
12.2M
94.5M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
BTOC
CGTX
Price
$0.26
$1.15
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
$3.33
AVG Volume (30 Days)
612.8K
624.0K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$190,408,258.00
N/A
Revenue This Year
$34.89
N/A
Revenue Next Year
$14.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
14.03
N/A
52 Week Low
$0.24
$0.22
52 Week High
$1.78
$3.83

Technical Indicators

Market Signals
Indicator
BTOC
CGTX
Relative Strength Index (RSI) 24.77 52.08
Support Level N/A $1.00
Resistance Level $0.43 $1.19
Average True Range (ATR) 0.04 0.07
MACD 0.00 0.02
Stochastic Oscillator 11.86 80.56

Price Performance

Historical Comparison
BTOC
CGTX

About BTOC Armlogi Holding Corp.

Armlogi Holding Corp is a fast-growing U.S.-based warehousing and logistics service provider that offers a comprehensive package of supply-chain solutions relating to warehouse management and order fulfillment. The company provides one-stop warehousing and logistics services to cross-border e-commerce merchants outside the U.S. who seek to sell in the U.S. market. The warehouses are equipped with automated sorting systems, heavy-duty forklifts, and pallets and trays that are suitable for processing bulky items. The services of the company include customs brokerage services, transportation of merchandise to U.S. warehouses, and warehouse management and order fulfillment services.

About CGTX Cognition Therapeutics Inc.

Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.

Share on Social Networks: